• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促动力蛋白和促动力蛋白受体在神经炎症中的多种作用

Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation.

作者信息

Lattanzi Roberta, Miele Rossella

机构信息

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.

Department of Biochemical Sciences "A. Rossi Fanelli", CNR Institute of Molecular Biology and Pathology, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.

出版信息

Biomedicines. 2021 Nov 9;9(11):1648. doi: 10.3390/biomedicines9111648.

DOI:10.3390/biomedicines9111648
PMID:34829877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8615546/
Abstract

Prokineticins are a new class of chemokine-like peptides involved in a wide range of biological and pathological activities. In particular, prokineticin 2 (PK2), prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2) play a central role in modulating neuroinflammatory processes. PK2 and PKRs, which are physiologically expressed at very low levels, are strongly upregulated during inflammation and regulate neuronal-glial interaction. PKR2 is mainly overexpressed in neurons, whereas PKR1 and PK2 are mainly overexpressed in astrocytes. Once PK2 is released in inflamed tissue, it is involved in both innate and adaptive responses: it triggers macrophage recruitment, production of pro-inflammatory cytokines, and reduction of anti-inflammatory cytokines. Moreover, it modulates the function of T cells through the activation of PKR1 and directs them towards a pro-inflammatory Th1 phenotype. Since the prokineticin system appears to be upregulated following a series of pathological insults leading to neuroinflammation, we will focus here on the involvement of PK2 and PKRs in those pathologies that have a strong underlying inflammatory component, such as: inflammatory and neuropathic pain, Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, obesity, diabetes, and gastrointestinal inflammation.

摘要

促动力蛋白是一类新的趋化因子样肽,参与广泛的生物学和病理学活动。特别是,促动力蛋白2(PK2)、促动力蛋白受体1(PKR1)和促动力蛋白受体2(PKR2)在调节神经炎症过程中起核心作用。PK2和PKRs在生理状态下表达水平极低,但在炎症期间会强烈上调,并调节神经元与神经胶质细胞的相互作用。PKR2主要在神经元中过度表达,而PKR1和PK2主要在星形胶质细胞中过度表达。一旦PK2在炎症组织中释放,它就会参与先天性和适应性反应:它触发巨噬细胞募集、促炎细胞因子的产生以及抗炎细胞因子的减少。此外,它通过激活PKR1来调节T细胞的功能,并将它们导向促炎的Th1表型。由于促动力蛋白系统在导致神经炎症的一系列病理损伤后似乎会上调,我们将在此重点关注PK2和PKRs在那些具有强烈潜在炎症成分的疾病中的作用,例如:炎性和神经性疼痛、阿尔茨海默病、帕金森病、多发性硬化症、中风、肥胖症、糖尿病和胃肠道炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b4/8615546/401a3e79cd40/biomedicines-09-01648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b4/8615546/c697e3969c05/biomedicines-09-01648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b4/8615546/401a3e79cd40/biomedicines-09-01648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b4/8615546/c697e3969c05/biomedicines-09-01648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b4/8615546/401a3e79cd40/biomedicines-09-01648-g002.jpg

相似文献

1
Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation.促动力蛋白和促动力蛋白受体在神经炎症中的多种作用
Biomedicines. 2021 Nov 9;9(11):1648. doi: 10.3390/biomedicines9111648.
2
Non-Peptide Agonists and Antagonists of the Prokineticin Receptors.促动力蛋白受体的非肽类激动剂和拮抗剂
Curr Issues Mol Biol. 2022 Dec 12;44(12):6323-6332. doi: 10.3390/cimb44120431.
3
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.趋化因子Bv8/促动蛋白2在炎性粒细胞中上调,并调节炎性疼痛。
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14646-51. doi: 10.1073/pnas.0903720106. Epub 2009 Aug 10.
4
Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2.激活杏仁核促动力素受体 2 神经元可驱动神经肽 PK2 的厌食活性。
J Biol Chem. 2023 Jan;299(1):102814. doi: 10.1016/j.jbc.2022.102814. Epub 2022 Dec 17.
5
Chemokines in Alzheimer's Disease: New Insights Into Prokineticins, Chemokine-Like Proteins.阿尔茨海默病中的趋化因子:对促动力蛋白、趋化因子样蛋白的新见解
Front Pharmacol. 2019 May 29;10:622. doi: 10.3389/fphar.2019.00622. eCollection 2019.
6
PK2/PKRs pathway is involved in the protective effect of artemisinin against trimethyltin chloride-induced hippocampal injury.PK2/PKRs 通路参与了青蒿素对三甲基氯化锡诱导的海马损伤的保护作用。
Toxicology. 2023 Mar 1;486:153432. doi: 10.1016/j.tox.2023.153432. Epub 2023 Jan 22.
7
-(4-[F]Fluoro-benzoyl)-'-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine-(4-[氟]氟苯甲酰基)-'-{2-[5-(4-氟苄基)-1-(4-甲氧基苄基)-4,6-二氧代-1,4,5,6-四氢-[1,3,5]三嗪-2-基氨基]-乙基}-胍
8
Bv8/Prokineticins and their Receptors A New Pronociceptive System.Bv8/促动力蛋白及其受体:一种新的伤害感受系统。
Int Rev Neurobiol. 2009;85:145-57. doi: 10.1016/S0074-7742(09)85011-3.
9
Abnormal Pain Sensation in Mice Lacking the Prokineticin Receptor PKR2: Interaction of PKR2 with Transient Receptor Potential TRPV1 and TRPA1.缺乏亲分泌素受体 PKR2 的小鼠异常疼痛感觉:PKR2 与瞬时受体电位 TRPV1 和 TRPA1 的相互作用。
Neuroscience. 2020 Feb 10;427:16-28. doi: 10.1016/j.neuroscience.2019.12.003. Epub 2019 Dec 26.
10
MRAP2 Inhibits β-Arrestin-2 Recruitment to the Prokineticin Receptor 2.MRAP2抑制β-抑制蛋白2募集至前动力蛋白受体2。
Curr Issues Mol Biol. 2024 Feb 17;46(2):1607-1620. doi: 10.3390/cimb46020104.

引用本文的文献

1
Synovial fluid as a complex molecular pool contributing to knee osteoarthritis.滑液作为促成膝关节骨关节炎的复杂分子库。
Nat Rev Rheumatol. 2025 Jul 7. doi: 10.1038/s41584-025-01271-4.
2
Genetic Polymorphisms of Prokineticins and Prokineticin Receptors Associated with Human Disease.与人类疾病相关的促动力蛋白和促动力蛋白受体的基因多态性
Life (Basel). 2024 Oct 1;14(10):1254. doi: 10.3390/life14101254.
3
Effects of Prokineticins on Cerebral Cell Function and Blood-Brain Barrier Permeability.胃动素对脑细胞功能和血脑屏障通透性的影响。

本文引用的文献

1
The balance of concentration between Prokineticin 2β and Prokineticin 2 modulates the food intake by STAT3 signaling.促动力蛋白2β与促动力蛋白2之间的浓度平衡通过信号转导和转录激活因子3(STAT3)信号通路调节食物摄入量。
BBA Adv. 2021 Oct 14;1:100028. doi: 10.1016/j.bbadva.2021.100028. eCollection 2021.
2
Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury.原癌基因蛋白-2 可预防创伤性脑损伤模型中的神经元细胞死亡。
Nat Commun. 2021 Jul 9;12(1):4220. doi: 10.1038/s41467-021-24469-y.
3
Changes in blood-spinal cord barrier permeability and neuroimmune interactions in the underlying mechanisms of chronic pain.
Int J Mol Sci. 2023 Oct 21;24(20):15428. doi: 10.3390/ijms242015428.
4
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model.促动力蛋白系统是对抗骨关节炎小鼠模型中的疼痛及其共病情绪改变的药理学靶点。
Cells. 2023 Sep 12;12(18):2255. doi: 10.3390/cells12182255.
5
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.靶向促动力素受体在疾病中的治疗潜力。
Pharmacol Rev. 2023 Nov;75(6):1167-1199. doi: 10.1124/pharmrev.122.000801. Epub 2023 Sep 8.
6
Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results.膝关节骨关节炎和创伤性半月板撕裂患者滑液中的促动力蛋白2和细胞因子含量:初步结果
J Clin Med. 2023 Jun 28;12(13):4330. doi: 10.3390/jcm12134330.
7
Special Issue "GPCR: Roles in Cell Development and Disease".特刊:G 蛋白偶联受体:在细胞发育和疾病中的作用
Int J Mol Sci. 2023 Apr 27;24(9):7943. doi: 10.3390/ijms24097943.
8
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis.阻断趋化因子受体可减轻胶原诱导性关节炎中的滑膜炎和关节破坏。
J Mol Med (Berl). 2023 May;101(5):569-580. doi: 10.1007/s00109-023-02307-6. Epub 2023 Mar 29.
9
Special Issue "G Protein-Coupled Receptors: Molecular Mechanisms Involved in Receptor Activation and Selectivity".特刊“G蛋白偶联受体:受体激活和选择性涉及的分子机制”
Life (Basel). 2023 Jan 6;13(1):166. doi: 10.3390/life13010166.
10
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy.基于液相色谱-串联质谱的代谢组学和蛋白质组学揭示了早期IgA肾病的候选生物标志物和分子机制。
Clin Proteomics. 2022 Dec 27;19(1):51. doi: 10.1186/s12014-022-09387-5.
血脊髓屏障通透性变化及神经免疫相互作用在慢性疼痛潜在机制中的作用
Pain Rep. 2021 Mar 9;6(1):e879. doi: 10.1097/PR9.0000000000000879. eCollection 2021.
4
Circulating Prokineticin 2 Levels Are Increased in Children with Obesity and Correlated with Insulin Resistance.肥胖儿童循环前动力蛋白2水平升高且与胰岛素抵抗相关。
Int J Endocrinol. 2021 Apr 4;2021:6630102. doi: 10.1155/2021/6630102. eCollection 2021.
5
The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes.促动力蛋白2在氧化应激和神经病理过程中的作用
Front Pharmacol. 2021 Mar 1;12:640441. doi: 10.3389/fphar.2021.640441. eCollection 2021.
6
Increase of Prokineticin-2 in Serum of Patients with Parkinson's Disease.帕金森病患者血清中促动力蛋白-2的增加。
Mov Disord. 2021 Apr;36(4):1031-1033. doi: 10.1002/mds.28458. Epub 2021 Jan 6.
7
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?阿尔茨海默病中的神经炎症和小胶质细胞激活:我们的路在何方?
Nat Rev Neurol. 2021 Mar;17(3):157-172. doi: 10.1038/s41582-020-00435-y. Epub 2020 Dec 14.
8
The Emerging Role of the Prokineticins and Homeobox Genes in the Vascularization of the Placenta: Physiological and Pathological Aspects.促动力蛋白和同源盒基因在胎盘血管生成中的新作用:生理和病理方面
Front Physiol. 2020 Nov 12;11:591850. doi: 10.3389/fphys.2020.591850. eCollection 2020.
9
Prokineticin receptor 1 ameliorates insulin resistance in skeletal muscle.促动力蛋白受体1改善骨骼肌中的胰岛素抵抗。
FASEB J. 2021 Feb;35(2):e21179. doi: 10.1096/fj.202001641R. Epub 2020 Nov 13.
10
Prokineticin Receptor Inhibition With PC1 Protects Mouse Primary Sensory Neurons From Neurotoxic Effects of Chemotherapeutic Drugs .PC1 抑制促动力素受体可保护小鼠原代感觉神经元免受化疗药物的神经毒性作用。
Front Immunol. 2020 Sep 24;11:2119. doi: 10.3389/fimmu.2020.02119. eCollection 2020.